NCT00134056 2021-10-27
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
SWOG Cancer Research Network
Phase 3 Completed
Clinical Trials
4 trialsNCT00046943 2011-02-21
Atrasentan in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00036556 2007-08-15
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
Abbott
Phase 3 Completed
NCT00036543 2006-08-15
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
Abbott
Phase 3 Completed